Capstone Therapeutics retires about 85% of convertible note principal, cuts balance to $1 million
Bitget2026/09/29 12:56- Capstone Therapeutics retired about 85% of its original $6.82 million convertible note principal through conversions, cutting the remaining balance to $1 million.
- The July 2025 convertible note has been fully retired; only the October 2025 note remains outstanding.
- Outstanding convertible note principal fell from $1.9 million as of June 30, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
